Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Molecular Biology|July 2, 2008
Beta-lactoglobulin assembles into amyloid through sequential aggregated intermediatesJason T Giurleo, Xianglan He, David S Talaga
The Journal of Physical Chemistry. B|August 19, 2008
Separation and analysis of dynamic Stokes shift with multiple fluorescence environments: coumarin 153 in bovine beta-lactoglobulin AJeremy Pronchik, Jason T Giurleo, David S Talaga
Journal of Molecular Biology|October 20, 2009
Role of small oligomers on the amyloidogenic aggregation free-energy landscapeXianglan He, Jason T Giurleo, David S Talaga
Journal of the American Chemical Society|June 29, 2010
In vitro formation of amyloid from alpha-synuclein is dominated by reactions at hydrophobic interfacesJeremy Pronchik, Xianglan He, Jason T Giurleo, et al.
The Journal of Physical Chemistry. B|August 18, 2006
Hidden Markov model analysis of multichromophore photobleachingTroy C Messina, Hiyun Kim, Jason T Giurleo, et al.
Molecular Cancer Therapeutics|March 2, 2023
A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late EndosomesAndres E Perez Bay, Devon Faulkner, John O DaSilva, et al.
Journal for Immunotherapy of Cancer|January 23, 2021
Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissuesMarcus P Kelly, Sosina Makonnen, Carlos Hickey, et al.
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Pageof 2